Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/0ET stock hub

FRA/0ET has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/0ETis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
686.7M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/0ETFRA/0ET
—
Loading chart…
In the news

Latest news · FRA/0ET

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.7
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC23.5
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/0ET market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
167
Groups with data
11
Currency
USD
Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
294
Employees Change
64%
Employees Change Percent
26.67
Enterprise value
EUR 1B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 686.7M
Price
EUR 2.63
Price currency
EUR
Rev Per Employee
1,233,819.8x
Sic
2834
Symbol
fra/0ET
Website
https://www.esperion.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
-0.94%
EV Earnings
-157.82x
EV/EBIT
15.78x
EV/EBITDA
15.24x
EV/FCF
-63.75x
EV/Sales
2.86x
FCF yield
-2.32%
Forward P/E
23.71x
P/B ratio
-2.57x
P/S ratio
1.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
18.12%
EBITDA Margin
18.15%
Gross margin
56.94%
Gross Profit
EUR 206.5M
Gross Profit Growth
74.23%
Gross Profit Growth Q
117.85%
Gross Profit Growth5 Y
21.66%
Net Income
EUR -6.4M
Pretax Margin
-1.33%
Profit Margin
-1.77%
Profit Per Employee
EUR -21,898
ROA
12.04
Roa5y
-18.63
ROCE
46.73
ROIC
23.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr10y
-14.43%
Cagr1y
251.38%
Cagr3y
27.67%
Cagr5y
-31.91%
Revenue Growth
61.13x
Revenue Growth Q
23.25x
Revenue Growth3 Y
72.86x
Revenue Growth5 Y
12.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
EUR 1.06
Assets
EUR 401.2M
Cash
EUR 135.4M
Current Assets
EUR 389.6M
Current Liabilities
EUR 254.7M
Debt
EUR 471.6M
Debt EBITDA
EUR 6.93
Debt FCF
EUR -29.59
Equity
EUR -267.1M
Interest Coverage
0.89
Liabilities
EUR 668.2M
Long Term Assets
EUR 11.5M
Long Term Liabilities
EUR 413.5M
Net Cash
EUR -336.2M
Net Cash By Market Cap
EUR -48.96
Net Debt EBITDA
EUR 5.11
Tangible Book Value
EUR -267.1M
Tangible Book Value Per Share
EUR -1.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.53
Inventory Turnover
1.39
Net Working Capital
EUR 74.1M
Quick ratio
0.96
Working Capital
EUR 138M
Working Capital Turnover
EUR 3.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-14.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
-78.94%
1Y total return
251.08%
200-day SMA
2.38
3Y total return
108.15%
50-day SMA
2.17
50-day SMA vs 200-day SMA
50under200
5Y total return
-85.36%
All Time High
111.4
All Time High Change
-97.64%
All Time High Date
2015-03-19
All Time Low
0.48
All Time Low Change
450.88%
All Time Low Date
2025-04-28
ATR
0.11
Ch YTD
-18.8
High
2.63
High52
3.5
High52 Date
2026-01-09
High52ch
-24.91%
Low
2.63
Low52
0.6
Low52 Date
2025-05-15
Low52ch
338.5%
Ma50ch
21.47%
Price vs 200-day SMA
10.69%
RSI
69.59
RSI Monthly
50.52
RSI Weekly
53.75
Sharpe ratio
1.57x
Sortino ratio
3.06
Total Return
-14.32%
Tr YTD
-18.8
Tr1m
31.55%
Tr1w
1.15%
Tr3m
0.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR 65.7M
Operating margin
18.12

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
255,155,376%
Net Borrowing
-46,563,289.3
Shares Insiders
0.87%
Shares Institutions
63.96%
Shares Qo Q
-11.67%
Shares Yo Y
14.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Adjusted FCF
EUR -24.5M
Average Volume
1,797.75x
Bv Per Share
-1.04
CAPEX
EUR -163,920
Ch10y
-78.94
Ch1m
31.55
Ch1w
1.15
Ch1y
251.1
Ch3m
0.88
Ch3y
108.1
Ch5y
-85.36
Ch6m
22.66
Change
0.77%
Change From Open
0
Close
2.61
Days Gap
0.77
Depreciation Amortization
89,884
Earnings Date
2026-05-07
EBIT
EUR 65.7M
EBITDA
EUR 65.8M
EPS
EUR -0.03
F Score
5
FCF
EUR -15.9M
FCF EV Yield
-1.57x
Financing CF
51,952,137
Fiscal Year End
December
Founded
2,008
Income Tax
EUR 1.6M
Investing CF
-163,920
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Ma150
2.57
Ma150ch
2.49%
Ma20
1.92
Ma20ch
37.1%
Net CF
36,014,633
Next Earnings Date
2026-08-04
Open
2.63
Ppne
2,554,061.5
Price Date
2026-05-08
Price EBITDA
EUR 10.43
Relative Volume
19.89x
Revenue
362,743,021x
SBC By Revenue
2.37x
Share Based Comp
8,592,341
Tax By Revenue
0.44x
Tr6m
22.66%
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/0ET pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/0ET stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+251.1%
S&P 500 1Y: n/a
3Y total return
+108.1%
S&P 500 3Y: n/a
5Y total return
-85.4%
S&P 500 5Y: n/a
10Y total return
-78.9%
S&P 500 10Y: n/a
Ownership

Who owns FRA/0ET?

Insider, institutional, and short-interest positioning.

Institutional ownership
+64.0%
Share of float held by funds and institutions
Insider ownership
+0.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+14.3%
Negative means the company is buying back shares.
Technical

FRA/0ET momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
69.6
Neutral momentum band
Price vs 200-day MA
+10.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.57
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/0ET

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/0ET stock rating?

fra/0ET is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/0ET analysis?

The full report lives at /stocks/fra/0ET/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/0ET?

The latest report frames fra/0ET around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/0ET page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.